Agency
Achievement Associates Center INC
Achievement Associates Center INC was paid $797K by Medicaid between Jan 2018 and Jun 2019, across 15 billing codes. Its largest line is 90834, psychotherapy session, about 45 minutes — 37% of everything it billed.
33Billing provider infoACHIEVEMENT ASSOCIATES CENTER INC
MEQUON, WI 53092
MEQUON, WI 53092
33aNPI1184159220assigned 04/26/2017
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$797K
24GClaims24,545
24DCodes billed15
24AFirst – last monthJan 2018 – Jun 2019
Compared with peers
Next to other Community/Behavioral Health Agency providers in Wisconsin
Rank by total paid#97 of 179
Median peer was paid$988K
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,669 | $560K | |
| 2019 | 6,876 | $236K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 37% | 6,139 | 3,843 | $292K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 18% | 1,384 | 1,117 | $142K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 4,513 | 3,308 | $104K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 8.9% | 2,392 | 1,058 | $71K |
| Q3014 | Telehealth originating site facility fee | 6.6% | 3,434 | 2,595 | $52K |
| 80305 | 5.8% | 4,363 | 2,487 | $47K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 4.4% | 546 | 520 | $35K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.7% | 1,158 | 968 | $22K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2.1% | 264 | 198 | $16K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 34 | 32 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 99 | 88 | $4K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 33 | 17 | $3K |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBINDER, ALAN (ADMINISTRATOR)